Figure 1From: Chronic myeloid leukemia (CML): association of treatment satisfaction, negative medication experience and treatment restrictions with health outcomes, from the patient’s perspective Multivariate structural equation model predicting the associations of CML treatment restrictions, treatment doses, NME, CML treatment satisfaction, and patient-reported outcomes among CML patients. Note. The following covariates or non-significant predictors (of adherence, activity impairment, MCS, PCS, and health utilities) are not presented: age, gender, number of comorbidities, time since diagnosis, and number of non-CML medications taken per day. Straight lines indicate betas and curved lines indicate correlations. Residual error terms, estimated for all predicted variables and factors, are not presented; neither are correlation estimates. Non-parenthetical values are standardized estimates (ranging from −1 to +1, with 0 = no effect) indicating strength and direction of association; these values can be compared across predictors. P-values are based on the unstandardized path estimates. No p-values are available for the first indicators per factor, which set the scale. Fit statistics indicate a fair fit of the data to the model (χ2 test of model fit=408.8; df=76; p-value<0.01. CFI=0.79; TLI=0.63; RMSEA=0.12). CML = chronic myeloid leukemia, NME = negative medication experience.Back to article page